---
title: "TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298077871.md"
description: "TherapeuticsMD Inc. (TXMD) shares fell 1.34% to $2.21, marking its second consecutive day of losses. Despite the decline, TXMD outperformed competitor AbbVie (ABBV), which dropped 1.44%. The stock remains 25.08% below its 52-week high of $2.95. Trading volume was significantly lower than the 50-day average."
datetime: "2026-09-04T21:30:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298077871.md)
  - [en](https://longbridge.com/en/news/298077871.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298077871.md)
generator: "portal-rs"
---

# TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) shed 1.34% to $2.21 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.29% to 26,506.99 and Dow Jones Industrial Average falling 0.51% to 53,414.25.

This was the stock's second consecutive day of losses.

TherapeuticsMD Inc. closed 25.08% short of its 52-week high of $2.95, which the company reached on January 27th.

Despite its losses, the stock outperformed some of its competitors Friday, as AbbVie Inc. (ABBV) fell 1.44% to $256.46.

Trading volume (7,785) remained 21,969 below its 50-day average volume of 29,754.

Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

09-04-26 1730ET

### Related Stocks

- [TXMD.US](https://longbridge.com/en/quote/TXMD.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors](https://longbridge.com/en/news/297235672.md)
- [Canada Pension Plan Investment Board Buys Shares of 3,248,582 AbbVie Inc. $ABBV](https://longbridge.com/en/news/298099969.md)
- [W1M Asset Management Ltd Acquires Shares of 5,460 AbbVie Inc. $ABBV](https://longbridge.com/en/news/297755003.md)
- [AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference | ABBV Stock News](https://longbridge.com/en/news/297911115.md)
- [AbbVie (NYSE:ABBV) Issues FY 2026 Earnings Guidance](https://longbridge.com/en/news/297966481.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**